[Therapeutic effect of tetracycline HCl and sulfaquinoxaline/trimethoprim in turkey bordetellosis].
D000372:Agglutination Tests; D000818:Animals; D000907:Antibodies, Bacterial / Q000096:biosynthesis; D001884:Bordetella / Q000276:immunology; D001885:Bordetella Infections / Q000188:drug therapy / Q000276:immunology / Q000662:veterinary*; D004359:Drug Therapy, Combination; D011200:Poultry; D011201:Poultry Diseases / Q000188:drug therapy* / Q000276:immunology; D013424:Sulfanilamides / Q000008:administration & dosage*; D013428:Sulfaquinoxaline / Q000008:administration & dosage*; D013752:Tetracycline / Q000008:administration & dosage*; D014295:Trimethoprim / Q000008:administration & dosage*; D014422:Turkeys
D000907:Antibodies, Bacterial; D013424:Sulfanilamides; D014295:Trimethoprim; D013752:Tetracycline; D013428:Sulfaquinoxaline
Zur therapeutischen Wirksamkeit von Tetracyclin . HCl und Sulfaquinoxalin/Trimethoprim bei der Puten-Bordetellose.